Sermonix has assembled a deep bench of talent within the women’s healthcare and oncology clinical development and commercialization arena.
David Portman, MD: CEO and Chief Medical Officer
Elizabeth Attias, ScD: VP of Business Development
Lawrence R. Hoffman, CPA, Esq.: Chief Financial Officer
Miriam Portman, MD: Chief Operating Officer
Paul Plourde, MD: VP, Oncology Clinical Development
Anthony H. Wild, Ph.D: Non-Executive Chairman of the Board
Barry Komm, Ph.D: Chief Scientific Officer